CRISPR Therapeutics AG (CRSP)
50.02
-1.53
(-2.97%)
USD |
NASDAQ |
Oct 13, 11:29
CRISPR Therapeutics Cash from Investing (Quarterly) : -55.66M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -55.66M |
| March 31, 2026 | -410.74M |
| December 31, 2025 | 37.20M |
| September 30, 2025 | -119.23M |
| June 30, 2025 | 69.98M |
| March 31, 2025 | -19.76M |
| December 31, 2024 | 105.83M |
| September 30, 2024 | -161.60M |
| June 30, 2024 | -126.90M |
| March 31, 2024 | -97.80M |
| December 31, 2023 | -81.45M |
| September 30, 2023 | 121.35M |
| June 30, 2023 | 216.92M |
| March 31, 2023 | 117.83M |
| December 31, 2022 | -175.53M |
| September 30, 2022 | 87.46M |
| June 30, 2022 | -56.07M |
| March 31, 2022 | -114.52M |
| December 31, 2021 | -8.716M |
| September 30, 2021 | -565.18M |
| June 30, 2021 | -293.64M |
| March 31, 2021 | -167.90M |
| December 31, 2020 | -204.24M |
| Date | Value |
|---|---|
| September 30, 2020 | -330.33M |
| June 30, 2020 | -3.605M |
| March 31, 2020 | -2.991M |
| December 31, 2019 | 7.057M |
| September 30, 2019 | -2.461M |
| June 30, 2019 | -2.174M |
| March 31, 2019 | -1.097M |
| December 31, 2018 | -1.00M |
| September 30, 2018 | -0.695M |
| June 30, 2018 | -0.523M |
| March 31, 2018 | -0.555M |
| December 31, 2017 | -0.205M |
| September 30, 2017 | -3.494M |
| June 30, 2017 | -1.33M |
| March 31, 2017 | -3.285M |
| December 31, 2016 | 17.22M |
| September 30, 2016 | -3.962M |
| June 30, 2016 | -1.047M |
| March 31, 2016 | 19.67M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | -0.102M |
| March 31, 2015 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -83.50M |
| Cash from Financing (Quarterly) | 7.18M |
| Free Cash Flow | -371.32M |
| Free Cash Flow Per Share (Quarterly) | -0.8719 |
| Free Cash Flow to Equity (Quarterly) | -80.25M |
| Free Cash Flow to Firm (Quarterly) | -84.15M |
| Free Cash Flow Yield | -7.83% |